Treatment of chronic posttraumatic stress disorder in combat veterans with citalopram: An open trial

Journal of Clinical Psychopharmacology

Volumn 26, Issue 1, 2006, Pages 84-88

  English, Brett A ^a   Jewell, Michele ^b   Jewell, George ^c   Ambrose, Sandra ^b   Davis, Lori L ^b,d  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAPHORESIS; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; DRUG SELECTIVITY; DRUG TOLERABILITY; FOLLOW UP; FUNCTIONAL ASSESSMENT; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; INSOMNIA; MALE; NAUSEA; OPEN STUDY; OUTCOME ASSESSMENT; PILOT STUDY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RATING SCALE; SEDATION; SIDE EFFECT; SOMNOLENCE; TREATMENT RESPONSE; VETERAN; XEROSTOMIA;

AGED; CITALOPRAM; COMBAT DISORDERS; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME; VETERANS;

EID: 31544444426     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000195043.39853.bc     Document Type: Article

References (27)

1. Kessler RC, Sonnega A, Bromet E, et al. Posttraumatic stress disorder in the national comorbidity survey. Arch Gen Psychiatry. 1995;52:1048-1060.
2. Kulka RL, Schlenger WE, Fairbank JA, et al. The National Vietnam Veterans Readjustment Study: Tables of Findings and Technical Appendices. New York, NY: Brunner/Mazel Publishers; 1990.
3. Davis LL, Nugent AL, Murray J, et al. Nefazodone treatment for chronic posttraumatic stress disorder: an open trial. J Clin Psychopharmacol. 2000;20(2):159-164.
4. Neylan TC, Marmar CR, Metzler TJ, et al. Sleep disturbances in the Vietnam generation: findings from a nationally representative sample of male Vietnam veterans. Am J Psychiatry. 1998;155:929-933.
5. Schatzberg AF. New indications for antidepressants. J Clin Psychiatry. 2000;61(suppl 11):9-17.
6. Lambert MT, Hendrickse W, Andrews R, et al. Malignant post-Vietnam stress syndrome revisited. J Ment Nerv Dis. 1996;184:354-357.
7. Davis LL, Suris A, Lambert MT, et al. Post-traumatic stress disorder and serotonin: new directions for research and treatment. J Psychiatry Neurosci. 1997;22(5):318-326.
8. Zisook S, Chentsova-Dutton YE, Smith-Vaniz A, et al. Nefazodone in patients with treatment-refractory posttraumatic stress disorder. J Clin Psychiatry. 2000;61:203-208.
9. Davis LL, English BA, Ambrose SM, et al. Pharmacotherapy for posttraumatic stress disorder: a comprehensive review. Exp Opin Pharmacother. 2001;2(10):1-12.
10. Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000;283(14):1837-1844.
11. Davidson J, van der Kolk B, Brady K, et al. Double-blind comparison of sertraline and placebo in patients with post-traumatic stress disorder. J Clin Psychiatry. 2000;61(7):40-43.
12. Tucker P, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62:860-868.
13. Hertzberg MA, Feldman ME, Beckham JC, et al. Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry. 2000;12:101-105.
14. Zohar J, Amital D, Miodownik C, et al. Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol. 2002;22:190-195.
15. Martenyi F, Brown EB, Zhang H, et al. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry. 2002;63(3):199-206.
16. De Vane CL. Differential pharmacology of newer antidepressants. J Clin Psychiatry. 1998;59(suppl 20):85-93.
17. Kugaya A, Seneca NM, Snyder PJ, et al. Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration. Neuropsychopharmacology. 2003;28(2):413-420.
18. Parker NG, Brown CS. Citalopram in the treatment of depression. Ann Pharmacother. 2000;34(6):761-771.
19. Seedat S, Stein DJ, Emsley RA. Open trial of citalopram in adults with post-traumatic stress disorder. Int J Neuropsychopharmacol. 2000;3: 135-140.
20. Seedat S, Lockhat R, Kaminer D, et al. An open trial of citalopram in adolescents with post-traumatic stress disorder. Int Clin Psychopharmacol. 2001;16:21-25.
21. Tucker P, Potter-Kimball R, Wyatt DB, et al. Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline and placebo. Psychopharmacol Bull. 2003;37(3):135-149.
22. Khouzam HR, el-Gabalawi F, Donnelly NJ. The clinical experience of citalopram in the treatment of post-traumatic stress disorder: a report of two Persian Gulf War veterans. Mil Med. 2001;166(10):921-923.
23. Frueh BC, Mirabella RF, Chobot K, et al. Chronicity of symptoms in combat veterans with PTSD treated by the VA mental health system. Psychol Rep. 1994;75:843-848.
24. Stein DJ, Seedat S, van der linden GJ. Selective serotonin reuptake inhibitors in the treatment of post-traumatic stress disorder; a metaanalysis of randomized controlled trials. Int J Clin Psychopharmacol. 2000;15(suppl 2):31-39.
25. Marmar CR, Schoenfeld F, Weiss DS, et al. Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder. J Clin Psychiatry. 1996;57(suppl 8):66-70.
26. Otte C, Wiedemann K, Yassouridis A, Kellner M. Valproate monotherapy in the treatment of civilian patients with non-combat-related posttraumatic stress disorder: an open-label study. J Clin Psychopharmacol. 2004;24(1):106-108.
27. Forbes D, Creamer M, Allen P, et al. The MMPI-2 as a predictor of symptom change following treatment for posttraumatic stress disorder. J Pers Assess. 2003;79(2):321-336.